Skip to content
akaturk Academic measurement
Sign in Sign up

OpenAlex topic

Endometrial and Cervical Cancer Treatments

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 4,443 works 152 author topics

Works

4,443 works

  1. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study 2010
    OpenAlex top 1% OpenAlex 100.0%

    No abstract yet.

  2. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up 2015
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%

    The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading exp…

  3. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer 2021
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%

    BACKGROUND: Pembrolizumab has efficacy in programmed death ligand 1 (PD-L1)-positive metastatic or unresectable cervical cancer that has progressed during chemotherapy. We assessed the relative benefit of adding pembrolizumab to chemotherapy with or without bevacizumab. METHODS: In a double-blind, phase 3 trial, we ra…

  4. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer 2021
    OpenAlex top 1% OpenAlex 100.0%

    BACKGROUND: Pembrolizumab has efficacy in programmed death ligand 1 (PD-L1)-positive metastatic or unresectable cervical cancer that has progressed during chemotherapy. We assessed the relative benefit of adding pembrolizumab to chemotherapy with or without bevacizumab. METHODS: In a double-blind, phase 3 trial, we ra…

  5. Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer 2022
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%

    BACKGROUND: Standard therapy for advanced endometrial cancer after failure of platinum-based chemotherapy remains unclear. METHODS: In this phase 3 trial, we randomly assigned, in a 1:1 ratio, patients with advanced endometrial cancer who had previously received at least one platinum-based chemotherapy regimen to rece…

  6. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer 2016
    YÖKSİS SJR Q2 JCR Q2 OpenAlex top 1% OpenAlex 99.8%

    No abstract yet.

  7. Endometriosis: Epidemiology, Diagnosis and Clinical Management 2017
    OpenAlex top 1% OpenAlex 99.9%

    No abstract yet.

  8. Regulation of Aromatase Expression in Estrogen Responsive Breast and Uterine Disease From Bench to Treatment 2005
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.3%

    No abstract yet.

  9. Progesterone resistance in endometriosis: Link to failure to metabolize estradiol 2006
    OpenAlex top 1% OpenAlex 99.6%

    No abstract yet.

  10. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva 2013
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.7%

    No abstract yet.

  11. SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer 2020
    OpenAlex top 1% OpenAlex 99.4%

    No abstract yet.

  12. Role of Estrogen Receptor-β in Endometriosis 2012
    OpenAlex top 1% OpenAlex 99.6%

    Endometriosis is an estrogen-dependent disease. The biologically active estrogen, estradiol, aggravates the pathological processes (e.g., inflammation and growth) and the symptoms (e.g., pain) associated with endometriosis. Abundant quantities of estradiol are available for endometriotic tissue via several mechanisms…

Academicians

152 academicians